Abbott Labs Stock Leapfrogs A Key Line Despite A Wild Card Obscuring 2022

Abbott Labs Stock Leapfrogs A Key Line Despite A Wild Card Obscuring 2022

Abbott Laboratories squashed third-quarter estimates Wednesday, helped by $1.9 billion in sales of Covid tests. ABT stock rose in response.